NCT02295774View on ClinicalTrials.gov

Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Colorectal Cancer
Interventions
PROCEDURE

standard white light colonoscopy-equivalent to placebo

standard white light colonoscopy

DRUG

Methylene Blue MMX tablets

8x25mg methylene blue MMX tablets administered before a colonoscopy

Trial Locations (1)

20089

IRCCS Instituto Clinico Humanitas, Rozzano

Sponsors
All Listed Sponsors
lead

Cosmo Technologies Ltd

INDUSTRY

NCT02295774 - Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA | Biotech Hunter | Biotech Hunter